Loading...

Centene Corporation

0HVB.LLSE
Healthcare
Medical - Equipment & Services
£26.01
£0.17(0.66%)

Centene Corporation (0HVB.L) Financial Performance & Income Statement Overview

Review Centene Corporation (0HVB.L) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
5.89%
5.89%
Operating Income Growth
8.36%
8.36%
Net Income Growth
22.32%
22.32%
Operating Cash Flow Growth
-98.09%
98.09%
Operating Margin
2.18%
2.18%
Gross Margin
49.35%
49.35%
Net Profit Margin
2.08%
2.08%
ROE
12.67%
12.67%
ROIC
4.16%
4.16%

Centene Corporation (0HVB.L) Income Statement & Financial Overview

Explore comprehensive income reports for Centene Corporation 0HVB.L, broken down by year and quarter.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$46.62B$40.80B$42.02B$39.84B
Cost of Revenue$41.42B$37.09B$37.99B$35.41B
Gross Profit$5.20B$3.72B$4.04B$4.43B
Gross Profit Ratio$0.11$0.09$0.10$0.11
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$3.35B$3.23B$3.06B$2.89B
Operating Expenses$3.67B$3.54B$3.37B$3.20B
Total Costs & Expenses$45.09B$40.63B$41.36B$38.61B
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$170.00M$172.00M$176.00M$176.00M
Depreciation & Amortization$315.00M$314.00M$313.00M$306.00M
EBITDA$2.23B$833.00M$1.41B$2.00B
EBITDA Ratio$0.05$0.02$0.03$0.05
Operating Income$1.53B$175.00M$665.00M$1.23B
Operating Income Ratio$0.03$0.004$0.02$0.03
Other Income/Expenses (Net)$212.00M$172.00M$256.00M$287.00M
Income Before Tax$1.75B$347.00M$921.00M$1.52B
Income Before Tax Ratio$0.04$0.009$0.02$0.04
Income Tax Expense$432.00M$67.00M$211.00M$370.00M
Net Income$1.31B$283.00M$713.00M$1.15B
Net Income Ratio$0.03$0.007$0.02$0.03
EPS$2.64$0.57$1.37$2.16
Diluted EPS$2.63$0.56$1.36$2.16
Weighted Avg Shares Outstanding$496.21M$500.42M$521.97M$529.60M
Weighted Avg Shares Outstanding (Diluted)$498.18M$501.98M$523.54M$530.75M

Over the last four quarters, Centene Corporation's revenue moved from $39.84B in Q2 2024 to $46.62B in Q1 2025. Operating income in Q1 2025 was $1.53B, with a strong operating margin of 3%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Centene Corporation remained robust at $2.23B, reflecting operational efficiency. Net income rose to $1.31B, with an EPS of $2.64. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;